Modulation of HLA-DQ Binding Properties by Differences in Class II Dimer Stability and pH-Dependent Peptide Interactions

Journal of Immunology

Volumn 157, Issue 11, 1996, Pages 4940-4945

  Buckner, Jane ^a,b   Kwok, William W ^a   Nepom, Barbara ^a,b   Nepom, Gerald T ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; PEPTIDE;

ALLELE; AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG STABILITY; GENETICS; HUMAN; IN VITRO STUDY; INVARIANT CHAIN; METABOLISM; MOLECULAR GENETICS; PH; PROTEIN BINDING; PROTEIN CONFORMATION;

ALLELES; AMINO ACID SEQUENCE; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; DRUG STABILITY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HUMANS; HYDROGEN-ION CONCENTRATION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 0030473602     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mellman, I., R. Fuchs, and A. Helenius. 1986. Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55:663 (Rev.).
2. Braciale, T. J., and V. L. Braciale. 1991. Antigen presentation: structural themes and functional variations. Immunol. Today 12:124.
3. Elliott, E. A., J. R. Drake, S. Amigorena, J. Elsemore, P. Webster, I. Mellman, and R. A. Flavell. 1994. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med. 179:681.
4. Chang, C. H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765.
5. Guagliardi, L. E., B. Koppelman, J. S. Blum, M. S. Marks, P. Cresswell, and F. M. Brodsky. 1990. Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 343:133.
6. Kwok, W. W., M. E. Domeier, F. C. Raymond, P. Byers, and G. T. Nepom. 1996. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156:2171.
7. Kwok, W. W., G. T. Nepom, and F. C. Raymond. 1995. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J. Immunol. 155: 2468.
8. Radku, S. F., S. Stewart, and S. Smith. 1985. Analysis of HLA-DQ molecules with a monoclonal antibody detecting a DQ polymorphism absent from DQw1 homozygous cells. Hum. Immunol. 14:206.
9. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
10. Kwok, W. W., M. E. Domeier, M. L. Johnson, G. T. Nepom, and D. M. Koelle. 1996. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J. Exp. Med. 183:1253.
11. Nepom, B. S., G. T. Nepom, M. Coleman, and W. W. Kwok. 1996. Critical contribution of β chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Proc. Natl. Acad. Sci. USA 93:7202.
12. g7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156:450.
13. Sidney, J., C. Oseroff, M. del Guercio, S. Southwood, J. I. Krieger, G. Y. Ishioka, K. Sakaguchi, E. Appella, and A. Sette. 1994. Definition of a DQ3.1-specific binding motif. J. Immunol. 152:4516.
14. Johansen, B. H., S. Buus, F. Vartdal, H. Viken, J. A. Eriksen, E. Thorsby, and L. M. Sollid. 1994. Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(α1*0501. β1*0201) molecule. Int. Immunol. 6:453.
15. Mukku, P. V., D. Passmore, D. Phan, and B. Nag. 1995. pH dependent binding of high and low affinity myelin basic protein peptides to purified HLA-DR2. Mol. Immunol. 32:555.
16. Harding, C. V., R. W. Roof, P. M. Allen, and E. R. Unanue. 1991. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 88:2740.
17. Mouritsen, S., A. S. Hansen, B. L. Petersen, and S. Buus. 1992. pH dependence of the interaction between immunogenic peptides and MHC class II molecules: evidence for an acidic intracellular compartment being the organelle of interaction. J. Immunol. 148:1438.
18. Sette, A., S. Southwood, D. O'Sullivan, F. C. A. Gaeta, J. Sidney, and H. M. Grey. 1992. Effect of pH on MHC class II-peptide interactions. J. Immunol. 148:844.
19. Sherman, M. A., H. A. Runnels, J. C. Moore, L. J. Stern, and P. E. Jensen. 1994. Membrane interactions influence the peptide binding behavior of DR1. J. Exp. Med. 179:229.
20. Reijonen, H., J. Ilonen, M. Sjoroos, A. Iitia, T. Lovgren, M. Knip, O. Simell, H. K. Akerblom, and Childhood Diabetes in Finland Study Group. 1995. Population based screening for the assessment of genetic susceptibility to IDDM in Finland. Autoimmunity 21:12 (Abstr.).
21. Witt, S. N., and H. M. McConnell. 1991. A first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 88:8164.
22. Jensen, P. E. 1991. Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH. J. Exp. Med. 174:1111.
23. Wettstein, D. A., J. J. Boniface, P. A. Reay, H. Schild, and M. M. Davis. 1991. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH. J. Exp. Med. 174:219.
24. Lee, J. M., C. M. Kay, and T. H. Watts. 1992. Conformational changes in mouse MHC class II proteins at acidic pH. Int. Immunol. 4:889.
25. DeWeese, C., W. W. Kwok, G. T. Nepom, and T. P. Lybrand. 1996. Characterization of a novel reverse-orientation model for a peptide-MHC complex putatively associated with type I diabetes mellitus. J. Mol. Model. 2:205.
26. Runnels, H. A., J. C. Moore, and P. E. Jensen. 1996. A structural transition in class II major histocompatibility complex proteins at mildly acidic pH. J. Exp. Med. 183:127.
27. Boniface, J. J., D. S. Lyons, D. A. Wettstein, N. L. Allbritton, and M. M. Davis. 1996. Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced. J. Exp. Med. 183:119.
28. d. Proc. Natl. Acad. Sci. USA 88:4661.
29. Jensen, P. E. 1990. Regulation of antigen presentation by acidic pH. J. Exp. Med. 171:1779.